期刊
EXPERT REVIEW OF CLINICAL IMMUNOLOGY
卷 6, 期 5, 页码 809-818出版社
TAYLOR & FRANCIS LTD
DOI: 10.1586/ECI.10.56
关键词
antimicrobial peptides; Crohn's disease; defensins; inflammatory bowel disease; innate immunity; Paneth cells; probiotics; ulcerative colitis
类别
Inflammatory bowel diseases are characterized by chronic intestinal inflammation at different sites. Data from animal models as well as human patients including gene-association studies suggest that different components of the innate barrier function are primarily defective. These recent advances support the evolving hypothesis that intestinal bacteria induce inflammation predominantly as a result of a weakened innate mucosal barrier in genetically predisposed individuals. This article discusses our current understanding of the primary events of disease. Together, these findings should result in new therapeutic avenues aimed at restoring antimicrobial barrier function to prevent a bacterial-triggered inflammatory response.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据